Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:TARO

Taro Pharmaceutical Industries (TARO) Stock Price, News & Analysis

Taro Pharmaceutical Industries logo

About Taro Pharmaceutical Industries Stock (NYSE:TARO)

Advanced Chart

Key Stats

Today's Range
$42.97
$42.97
50-Day Range
$42.20
$42.99
52-Week Range
$32.67
$45.76
Volume
N/A
Average Volume
45,199 shs
Market Capitalization
$1.62 billion
P/E Ratio
29.84
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TARO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Taro Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.

TARO Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

TARO Stock Analysis - Frequently Asked Questions

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) released its quarterly earnings data on Thursday, October, 28th. The company reported $0.66 EPS for the quarter, missing the consensus estimate of $1.02 by $0.36. The business earned $131.99 million during the quarter, compared to analysts' expectations of $153.23 million. Taro Pharmaceutical Industries had a net margin of 8.56% and a trailing twelve-month return on equity of 3.75%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Taro Pharmaceutical Industries investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
10/28/2021
Today
7/13/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:TARO
CIK
906338
Employees
1,554
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$1.44
Trailing P/E Ratio
29.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$53.87 million
Net Margins
8.56%
Pretax Margin
13.14%
Return on Equity
3.75%
Return on Assets
3.09%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.61
Quick Ratio
3.04

Sales & Book Value

Annual Sales
$629.18 million
Price / Sales
2.57
Cash Flow
$2.38 per share
Price / Cash Flow
18.03
Book Value
$47.70 per share
Price / Book
0.90

Miscellaneous

Outstanding Shares
37,590,000
Free Float
32,400,000
Market Cap
$1.62 billion
Optionable
Optionable
Beta
0.56
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:TARO) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners